Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of DSP-7888 in Patients With Myelodysplastic Syndrome (MDS)

NCT02436252 is registered in ClinicalTrials.gov with Sumitomo Pharma Co., Ltd. as lead sponsor.

NCT NCT02436252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02436252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of DSP-7888 in Patients With Myelodysplastic Syndrome (MDS)
Lead sponsor
Sumitomo Pharma Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2015
Completion date
March 31, 2020
Enrollment
48 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome